RxDoctor Payments Data

Erica Gunnells

Family · Charleston, SCNPI 1912131285

Payments from drug & device makers

$7,112in general payments, 2019–2025

Across 376 payments — averaging $18.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bayer$1K
  • Lilly USA, LLC$646
  • Sanofi-aventis U.S. LLC$594
  • AbbVie$527
  • Xeris Pharmaceuticals, Inc.$489
  • Medtronic$433
  • plus $3K from 37 others

What the payments were for

  • Food & beverage$7,112100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$7,112 in reported general payments places this provider in the 95th percentile of 3,248 family providers in South Carolina.

See all family providers in South Carolina

Medicare billing

Part B allowed, 2024
$100,507
Medicare patients
157
Services billed
8,423

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide489$653,722
Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/7116$189,891
OzempicSemaglutide90$148,350
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog85$107,909
JardianceEmpagliflozin95$92,715
JanuviaSitagliptin Phosphate73$77,700
TrulicityDulaglutide42$71,244
Tresiba Flextouch U-200Insulin Degludec51$64,118
RybelsusSemaglutide38$57,493
Humalog Kwikpen U-200Insulin Lispro13$53,175
FarxigaDapagliflozin Propanediol24$34,917
Janumet XrSitagliptin Phos/Metformin Hcl33$26,362
KerendiaFinerenone20$23,248
Fiasp FlextouchInsulin Aspart (Niacinamide)11$17,212
Trijardy XrEmpaglifloz/Linaglip/Metformin21$16,863

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity, Humalog, Insulin Lispro$646$743,038583 claims
Novo NordiskOzempic, Rybelsus, Novolog, Novolog Mix 70-30$194$215,501158 claims
Boehringer IngelheimJardiance, Trijardy Xr$53$109,578116 claims
MerckJanuvia, Janumet Xr$12$104,062106 claims
AstraZenecaFarxiga$52$34,91724 claims
BayerKerendia$1,029$23,24820 claims
AbbVieSynthroid$527$11,807105 claims
Antares Pharma, Inc.Xyosted$86$8,25113 claims
Amneal Pharmaceuticals LLCUnithroid$293$53923 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,248 family providers in South Carolina.

Other family in Charleston

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →